AXSM Company Profile and Key Details
Axsome Therapeutics, Inc.
AXSM Stock Price Chart
Stock Price Today
Axsome Therapeutics, Inc. (AXSM) stock surged +5.11%, trading at $112.92 on NASDAQ, up from the previous close of $107.43. The stock opened at $108.52, fluctuating between $108.00 and $113.32 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Company Information
| Employees | 607 |
| Beta | 1.25 |
| Sales or Revenue | $270.60M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock price is $112.92 in the last trading session. During the trading session, AXSM stock reached the peak price of $113.32 while $108.00 was the lowest point it dropped to. The percentage change in AXSM stock occurred in the recent session was 5.11% while the dollar amount for the price change in AXSM stock was $5.49.
The NASDAQ listed AXSM is part of Biotechnology industry that operates in the broader Healthcare sector. Axsome Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Nick Pizzie CPA, M.B.A.
Chief Financial Officer
Mr. Hunter Murdock Esq.
Gen. Counsel & Sec.
Mr. Kevin Laliberte Pharm.D.
Executive Vice President of Product Strategy
Ms. Lori Englebert M.B.A.
Executive Vice President of Commercial & Bus. Devel.
Mr. Mark L. Jacobson
Chief Operating Officer & Sec.
Dr. Amanda Jones Pharm.D.
Senior Vice President of Clinical Devel.
Dr. Herriot Tabuteau M.D.
Founder, Chairman, Chief Executive Officer & Pres
Joseph Debrah-Afful CPA, M.B.A.
Director of Fin.
AXSM's closing price is 76.14% higher than its 52-week low of $64.11 where as its distance from 52-week high of $113.32 is -0.35%.
Number of AXSM employees currently stands at 607.
Official Website of AXSM is: https://www.axsome.com
AXSM could be contacted at phone 212 332 3241 and can also be accessed through its website. AXSM operates from 22 Cortlandt Street, New York, NY 10007, United States.
AXSM stock volume for the day was 772.3K shares. The average number of AXSM shares traded daily for last 3 months was 774.52K.
The market value of AXSM currently stands at $5.47B with its latest stock price at $112.92 and 48.46M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com